Back to Search
Start Over
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections
- Publication Year :
- 2022
-
Abstract
- In this post-hoc analysis of data from a randomised clinical trial, we compared the effect of liraglutide to placebo on markers of insulin secretion in persons with type 2 diabetes treated with multiple daily insulin injections. Liraglutide increased insulin secretion, measured by C-peptide, by 19% after 24 weeks of treatment.<br />Funding Agencies|Novo NordiskNovo Nordisk
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1312843987
- Document Type :
- Electronic Resource
- Full Text :
- https://doi.org/10.1016.j.jdiacomp.2021.108110